Clinical Trials Directory

Trials / Completed

CompletedNCT03227536

Asphyxia at Birth : Causes and Neonatal Outcome

Asphyxia at Birth : Evolution of Birth Asphyxia Rate, Etiologies and Neonatal Outcome From 2000 to 2016

Status
Completed
Phase
Study type
Observational
Enrollment
61,448 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
1 Hour
Healthy volunteers
Not accepted

Summary

This is an historic cohort study based on the birth and delivery register of the HFME maternity ward. This study aim at understanding the evolution of asphyxia at birth, at all gestational ages, identifying causes and describing neonatal outcomes since 2000, when a second line strategy for foetal surveillance (fetal ECG) and systematic umbilical acid-gas cord blood were introduced in our maternity ward. The investigator's hypothesis was that the neonatal asphyxia decrease could be due to 3 main factors including second line strategy introduction, systematic umbilical cord acid-base implementation and improvement in antenatal risk factor screening for asphyxia. The investigator's second hypothesis was that neonatal prognosis in neonates with acidosis was improved with systematic early after birth EEG evaluation, allowing early treatment and surveillance.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2017-07-24
Last updated
2017-07-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03227536. Inclusion in this directory is not an endorsement.